CMED Technologies Ltd.
9Patents
9Active
9Granted
39Portfolio score
Filing activity: Jul 31, 2007 → Oct 4, 2007 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8153445B2 | Method for screening of infectious agents in blood | Emerging Cross-Sectional Technologies | 1 | Active |
| US8158342B2 | Method for the identification of human immunodeficiency virus related antibodies in blood | Emerging Cross-Sectional Technologies | 1 | Active |
| US8114682B2 | Method for the quantitative evaluation of sex hormones in a serum sample | Emerging Cross-Sectional Technologies | 0 | Active |
| US8158343B2 | Method to detect virus related immunological markers for the diagnosis of respiratory tract infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US8158440B2 | Method for quantitative measurement of thyroid related antibodies or antigens in a serum sample | Emerging Cross-Sectional Technologies | 0 | Active |
| US8110408B2 | Method for quantitative detection of diabetes related immunological markers | Emerging Cross-Sectional Technologies | 0 | Active |
| US8110409B2 | Method to measure serum biomarkers for the diagnosis of liver fibrosis | Emerging Cross-Sectional Technologies | 0 | Active |
| US8119350B2 | Method of surface plasmon resonance (SPR) to detect genomic aberrations in patients with multiple myeloma | Emerging Cross-Sectional Technologies | 0 | Active |
| US8168379B2 | Application of surface plasmon resonance technology for detecting and genotyping HPV | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.